Mindfulness Training in Special Operations Forces (SOF) Candidates

January 11, 2023 updated by: Amishi Jha, University of Miami
The overarching goal of this study is to develop, deliver, and investigate the utility and feasibility of train-the-trainer delivery of mindfulness training (MT) in support of improved readiness (across cognitive, affective, and social domains of the human dimension) and improve retention of candidates in the SOF qualification pipeline at the U.S. Army John F. Kennedy Special Warfare Center and School (referred to as SWCS).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

245

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Coral Gables, Florida, United States, 33146
        • University of Miami

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals who are between 18 and 65 years of age.
  • Individuals who are fluent English speakers.
  • Individuals who are active-duty service members.
  • Men and women of all races and ethnicities.
  • Individuals who are willing and able to consent to participate in the study.
  • Individuals who are attending Special Warfare Center and School (SWCS).

Exclusion Criteria:

  • Individuals who have a medical or neurological condition that might interfere with performance on the task in the study (e.g., epilepsy)
  • Individuals with a history of hospitalization for psychological/mental health issues within the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness training (MT) group
Receives 4 weeks of mindfulness training followed by a testing session.

The MBAT will involve:

(i) 4 weekly 1.5-hour course sessions. The sessions will provide guided exercises, didactic information, and discussions to promote greater mindfulness.

(ii) Daily mindfulness practice that will be facilitated by the Measuring Mindfulness App (MMA) and/or instructor-delivered mindfulness practices. The daily mindfulness practice will require about 15 minutes to complete.

No Intervention: No-training control (NTC) group
Receives 4 weeks of no mindfulness training followed by a testing session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Attentional Performance
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Attentional Performance as measured by the Sustained Attention Response Task (SART). SART has a range of scores from 0 to 1 with a higher score indicating better accuracy of completing the task.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Working Memory Performance
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Working Memory Performance as measured by the Working Memory Task with Affective Distracters (WMDA). WMDA has a range of scores from 0 to 100%, with higher scores indicating better accuracy on the task.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Cognitive Failures
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Cognitive Failures will be measured by the Cognitive Failures Questionnaire (CFQ). CFQ has total score ranging from 0 to 100, with a higher score indicating more cognitive failures.
Baseline (week 1) to week 6 (after 4-week training interval)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Positive Affect
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Positive Affect will be measured by the Positive and Negative Affect Schedule (PANAS-10). The PANAS Positive has a range of scores from 5 to 25, with higher score indicating higher positive mood.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Negative Affect
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Negative Affect will be measured by the Positive and Negative Affect Schedule (PANAS-10). The PANAS Negative has a range of scores from 5 to 25, with higher score indicating higher negative mood.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Perceived Stress
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
The short version of the Perceived Stress Scale (PSS) will be used assess perceived stress. The 4-item PSS has a range of scores from 0 to 16, with higher score indicating higher level of perceived stress.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Psychological Health
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Patient Health Questionnaire (PHQ-4) will be used to assess depression and anxiety. PHQ-4 has a range of scores from 0 to 12, with higher scores indicating higher level of depression and anxiety.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Decentering
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
EQ Decentering is an 11-item sub-scale measuring various thoughts and experiences, and the tendency to distance from those. The decentering score ranges from 1 to 55, with a higher score indicating high level of decentering.
Baseline (week 1) to week 6 (after 4-week training interval)
Change in Mind Wandering
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
Four Factor Mind Wandering (4FMW) Questionnaire is a 16-item scale that asks participants to indicate how often they experience a situation described in the form of a statement on a 5-point Likert-type scale from never (1) to always (5). 4FMW has a range of scores from 16 to 80, with higher scores indicating greater mind wandering.
Baseline (week 1) to week 6 (after 4-week training interval)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Post-Traumatic Stress Disorder (PTSD) symptomatology
Time Frame: Baseline to week 6 and week 11.
Post-traumatic Stress Disorder Checklist for military populations (PCL-M) will be used to measure symptoms of PTSD. PCL-M has a range of scores from 17 to 85, with higher scores indicating more PTSD symptoms.
Baseline to week 6 and week 11.
Change in Perspective Taking
Time Frame: Baseline (week 1) to week 6 (after 4-week training interval)
The Perspective Taking (PT) Subscale from the Interpersonal Reactivity Index (IRI) will be used to assess perspective-taking. The PT Subscale score ranges from 0 to 28, with a higher score indicating greater perspective-taking.
Baseline (week 1) to week 6 (after 4-week training interval)
Applied Mindfulness Process Scale
Time Frame: post training at at week 6
Applied Mindfulness Process Scale measures how often people apply mindfulness practice in daily life.
post training at at week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Amishi Jha, University of Miami

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 16, 2022

Primary Completion (Actual)

December 7, 2022

Study Completion (Actual)

January 9, 2023

Study Registration Dates

First Submitted

January 7, 2021

First Submitted That Met QC Criteria

January 7, 2021

First Posted (Actual)

January 11, 2021

Study Record Updates

Last Update Posted (Actual)

January 12, 2023

Last Update Submitted That Met QC Criteria

January 11, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 20201488
  • W81XWH20C0065 (Other Grant/Funding Number: Department of Defense)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Change

Clinical Trials on MBAT course

3
Subscribe